abcam
ab203491
![兔单克隆抗体[EPR22059-270] to PDGF Receptor alpha](/UpLoad/Images/202605/bgrac30a251c.jpg)
兔单克隆抗体[EPR22059-270] to PDGF Receptor alpha
Anti-PDGFR alpha antibody [EPR22059-270] (ab203491) is a rabbit monoclonal antibody detecting PDGFR alpha in Western Blot, Flow Cytometry, IP, IHC-P, IHC-Fr, ICC/IF, ELISA. Suitable for Human, Mouse, Rat. - KO validated for confirmed specificity - Biophysical QC for unrivalled batch-batch consistency - Over 30 publications
产品简介
Anti-PDGFR alpha antibody [EPR22059-270] (ab203491) was developed by Abcam using patented rabbit monoclonal antibody technology and is validated for use in Flow Cyt, I-ELISA, ICC/IF, IHC-Fr, IHC-P and IP.
Abcam's high quality manufacturing and validation processes ensure Anti-PDGFR alpha antibody [EPR22059-270] (ab203491) has high sensitivity and specificity alongside high lot-to-lot consistency and reproducibility.
The specificity of Anti-PDGFR alpha antibody [EPR22059-270] (ab203491) has been confirmed by Western Blot testing in PDGFR alpha knockout SH-SY5Y cells (ab275335 ).
Anti-PDGFR alpha antibody [EPR22059-270] (ab203491) has 4 independent reviews from customers.
Anti-PDGFR alpha antibody [EPR22059-270] (ab203491) specifically detects PDGFR alpha (UniProt ID: P16234; Molecular weight: 121kDa) and is sold in a convenient trial size to enable initial testing (20 µL) and larger sizes for subsequent scaling up experiments (100 µL and 1 mL).
Conjugation-ready, carrier free format available for antibody clone EPR22059-270 - ab234965.
Antibody clone EPR22059-270 is also available pre-conjugated to a variety of labels for your convenience - Alexa Fluor® 647, PE, Alexa Fluor® 488 (ab270085, ab270086, ab307855).
The platelet-derived growth factor receptor alpha (PDGFRA) is a cell surface tyrosine kinase receptor that plays a significant role in tumor growth, invasion and angiogenesis in oncology often serving as a therapeutic target due to its overexpression in various cancers, particularly in gastrointestinal stromal tumors (GISTs),
Patented technologyOur RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.
What are the advantages of a recombinant monoclonal antibody?This product is a recombinant monoclonal antibody, which offers several advantages including:
- - High batch-to-batch consistency and reproducibility
- - Improved sensitivity and specificity
- - Long-term security of supply
- - Animal-free batch production
产品参数
